Editorial: Challenge of Managing Cancer-Related Fatigue JCO

"...Ultimately, the best intervention for CRF will be the development of a personalized treatment plan based on the identification of the main contributing factors to fatigue in a given patient followed by evidence-based combined therapies.
One more important contribution of this study by Moraska et al7**
is that it demonstrates that clinical trials of agents for the management
of fatigue can be successfully completed by cooperative clinical trial
groups. This is of great importance for the development of a body of
knowledge on supportive and palliative interventions for patients
with cancer."

** 7. Moraska AR, Sood A, Dakhil SR, et al: Phase III, randomized, double-blind,placebo-controlled study of long-acting methylphenidate for cancer-related fatigue:NCCTG Trial NO5C7. J Clin Oncol doi: 10.1200.JCO.2010.28.1444